sprite-preloader
Anzeige
Mehr »
Sonntag, 09.12.2018 Börsentäglich über 12.000 News von 600 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrJeans and other drugs: Novartis CEO Narasimhan's prescription for a millennial-friendly culture
FrAstraZeneca's Imfinzi fails another phase 3 trial, this time in head and neck cancer
FrTris Pharma recalls potentially harmful infants' ibuprofen
FrWith pricing outcry raging, U.S. drug spending grew less than 1% last year: CMS
FrWith Tesaro off the block, will Clovis be the next PARP maker to get swallowed up?
FrFiercePharmaAsia-Takeda-Shire finish line; Sun's crisis; J&J-Legend CAR-T
FrRoche's Tecentriq wins key lung cancer approval. Its prize? A showdown with formidable Merck
FrActelion inks $360M deal to resolve DOJ kickbacks probe
DoTroubled Mallinckrodt spins off specialty generics business in ongoing effort to reshape its image
DoBREAKING: Actelion inks $360M deal to resolve DOJ kickbacks probe
DoBig pharma's off-patent drugs lose out in China's new price-cutting scheme
DoSandoz prepares early 2019 launch for EpiPen alternative Symjepi at 16% discount
DoAkorn fights to salvage Fresenius deal in appeal to Delaware Supreme Court
DoNovartis, aiming to protect blockbuster sales, advances Xolair follow-up to phase 3
DoNews of Note - Mylan now recalling 104 lots of valsartan medications
DoSanofi plots 670 layoffs in France as local tensions brew
DoRoche's Tecentriq lines up for billion-dollar market with FDA priority tag
DoCatalent is expanding and adding 36 jobs at its Indiana biologics plant
MiNovo keeps adding capacity, and jobs, to its North Carolina drug plant
MiAstraZeneca's Calquence found success in lymphoma. Will CLL follow?
MiTaking aim at Medicaid misclassifications like Mylan's EpiPen, senators look to end a 'pharma ripoff'
MiChinese drugmaker pours $145M into plant with plan to produce innovative biologics
MiTakeda CEO gets his Shire megamerger, thanks to shareholder nod. Can he make it pay off?
MiNews of Note - Gardasil-Cervarix divide, flu vaccines and more
MiMismanagement allegations send Sun Pharma stock tumbling: What we know so far